- a multidisciplinary research team.
- Integrated translational research.
- State-of-the-art infrastructure.
- Phase I vaccine research platform.
- Platform for clinical studies on antimicrobial resistance.
- 'bedside to bench' delivery timelines to quickly adjust the vaccine development process.
- High-tech Cellular Immunology facilities, including GMP cell processing units.
⇒ A combination of high quality infrastructure with state-of-the-art
technology for biomarker identification and diagnostic development